Elos Medtech appoints Ewa Linsäter as new CFO

Elos Medtech appoints Ewa Linsäter as new CFO for the Elos Medtech Group.

Ewa Linsäter has held various leading positions within finance and most recently from REAC Group. Ewa holds an MBA in Economics from University of Linköping and started her carrier within PwC. She has long experience within the industry, for instance from Gunnebo and Ernströmgruppen.

“We welcome Ewa to Elos Medtech when we continue on our growth journey. Ewa has extensive experience from several industries where she has been involved in creating profitable growth. Ewa will be a great asset in our management team”, says Jan Wahlström, CEO and President.

Ewa will take up her position as CFO at Elos Medtech by the end of June 2019.

Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, with focus on dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are medical technology companies operating internationally.

Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Gothenburg, March 28, 2019

Elos Medtech AB (publ)

For further information, contact:

Jan Wahlström, President and CEO, +46 70-212 18 89, jan.wahlstrom@elosmedtech.com 

 

This is the type of information that Elos Medtech AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was issued for publication by the contact persons stated above on March 28, 2019, at 18.00 (CET). 

For additional information about the Elos Medtech Group, visit www.elosmedtech.com

Tags:

About Us

Elos Medtech is one of the leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental , Orthopedics and Life Science. Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.